Prenetics Global (PRE) Income from Non-Controlling Interests (2021 - 2025)
Prenetics Global's (PRE) quarterly Income from Non-Controlling Interests came in at -$42000.0 in Q4 2025, up 96.5% year-over-year from -$21374.0 in Q4 2024, and up 96.73% quarter-over-quarter from -$1.3 million in Q3 2025.
Analysis
Prenetics Global (PRE) Income from Non-Controlling Interests (2021 - 2025) Analysis & Trends
Prenetics Global (PRE) has reported Income from Non-Controlling Interests for 5 consecutive years, with -$42000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Income from Non-Controlling Interests rose 96.5% year-over-year to -$42000.0 in Q4 2025; TTM through Dec 2025 was -$2.3 million, a 35.2% increase from a year earlier, with the FY2025 full-year figure at -$2.3 million, up 35.21% from the prior year.
- Income from Non-Controlling Interests was -$42000.0 for Q4 2025 at Prenetics Global, up from -$1.3 million in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at -$1000.0 in Q2 2022 and troughed at -$7.6 million in Q4 2021.
- A 5-year average of -$1.2 million and a median of -$542654.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
- Across the five-year window, Income from Non-Controlling Interests soared 99.96% in 2022 and sank 39887.7% in 2023, its largest moves.
- Over 5 years, Income from Non-Controlling Interests stood at -$7.6 million in 2021, then surged by 99.29% to -$54000.0 in 2022, then slumped by 3701.85% to -$2.1 million in 2023, then surged by 41.55% to -$1.2 million in 2024, then soared by 96.5% to -$42000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at -$42000.0 (Q4 2025), -$1.3 million (Q3 2025), and -$317000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 13.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | - |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | - |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | - |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | - |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 200,000.00 |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -42,000.00 |
| Sep 30, 2025 | -1.29 Mn |
| Jun 30, 2025 | -317,000.00 |
| Mar 31, 2025 | -626,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -1.40 Mn |
| Jun 30, 2024 | -424,000.00 |
| Mar 31, 2024 | -484,000.00 |
| Dec 31, 2023 | -2.05 Mn |
| Sep 30, 2023 | -509,998.00 |
| Jun 30, 2023 | -399,877.00 |
| Mar 31, 2023 | -575,310.00 |
| Dec 31, 2022 | -54,000.00 |
| Sep 30, 2022 | -8,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -46,000.00 |
| Dec 31, 2021 | -7.57 Mn |
| Sep 30, 2021 | -2.42 Mn |
| Jun 30, 2021 | -2.67 Mn |
| Mar 31, 2021 | -2.45 Mn |